Industry Overview The Problem Though the ability of preventing Ischemic Stroke is real, current modalities and procedures do not allow for intervention prior to the occurrence A patient is only sent for arterial evaluation if they are presenting symptoms of stroke, and since stroke is frequently asymptomatic there typically is no further testing There is a high cost associated with current screening modalities available (Duplex Doppler Ultrasound, MRA, CTA, and Digital Subtraction) which compound this problem Stroke/Carotid Artery Disease Statistics Leading Cause of Disability (Globally) 3rd Leading Cause of Death (USA) Asymptomatic 795,000 Stroke Incidents Yearly (USA) Ischemic 87% Hemorrhagic 13% 3rd Leading Cause of Death (USA) Permanent Impairment 50% Recover 38% Fatal 12% Cost 2010 $71.6 Billion 2030 Cost Estimated to Triple Current Modalities for CAD Screening / Early Detection: COMING SOON Carotid Stenotic Scan (CSS) $55,000 No Certified Tech Required Dr. Fee: $125 / Estimated Reimbursement: $105 Per Scan Non-Emitting Non-Invasive Accurate & Repeatable 2 Minute Scan Carotid Doppler Ultrasound $250,000 Requires Radiological Assistant (Salary $75k - $100k) Reimbursement: $180-$400 Per Scan Emits High Energy Sound Wave Non-Invasive Accuracy is User Dependent 30 - 60 Minute Process Magnetic Resonance Angiography (MRA) $1-2,5M Requires Radiological Assistant (Salary $75k - $100k) Reimbursement: $3,000 Per Scan Emits Radiation Contrast Agent Used Accuracy is User Dependent >60 Minute Process Computed Tomography Angiography (CTA) $1-2,5M Requires Radiological Assistant (Salary $75k - $100k) Reimbursement: $500 - $1,500 Per Scan Emits Radiation Contrast Agent Used Accuracy is User Dependent 30 - 60 Minute Process Stay Informed - Sign Up for Updates & News About CVR Medical CVR Medical Corp. is a med-tech organization dedicated to the development and advancement of revolutionary technology at work within the healthcare sector. Specifically, The Carotid Stenotic Scan (CSS), a groundbreaking tool which will be used to assess Carotid Arterial health in a way which is unavailable to the patient, healthcare provider, and the payor within the current system. By leveraging intellectual property, market and industry know-how, and key strategic relationships, CVR Medical has entered into a trajectory which will revolutionize healthcare and dramatically improve clinical outcomes. Follow Us Recent News CVR Medical Corp. Provides an Update on Restructuring Agreement and Severance Agreement with Former CEO CVR Medical Corp. Announces Reinstatement of Trading by the TSX-v and Delay in Filing of Annual and Interim Financial Statements and MD&A CVR Medical Corp. Announces Addition to Board of Directors CVR Medical Corp. Announces Additional Directors Twitter Feed CVR Medical Corp 3 years ago #CVRMedical receives IRB approval for Clinical Trial at Prestigious Mayo Clinic - Read More CVR Medical Corp 3 years ago @CVRMed submits CSS Device to FDA - Read More CVR Medical Corp 3 years ago CVR Medical announces closing of transaction with CVR Global - Read More Copyright © 2021 by CVR Medical Crop. | All Rights Reserved | Disclaimer | Website Designed by 702 Pros